Capmatinib uses
Capmatinib (Capmatinib) is a targeted therapy drug, mainly used to treat patients with MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC). METExon 14 skipping mutation is a relatively rare but biologically important genetic mutation in NSCLC patients. It leads to abnormal activation of MET kinase, thereby promoting the development of lung cancer.
The main uses of capmatinib can be summarized in the following aspects:
1. Targeted therapyMETExon14Skipping mutantNSCLC: Capmatinib specifically inhibits the activity of MET kinase and targets the MET exon 14 skipping mutant, thereby blocking abnormal signaling pathways. This targeted therapeutic effect makes capmatinib an effective drug option for patients with MET exon 14 skipping mutant NSCLC.
2. Improve the objective response rate: Clinical trial data show that capmatinib has a significant objective response rate in METExon14skipping mutant NSCLC patients, even in patients who have failed previous treatment options.
3. Prolong survival: Capmatinib treatment can significantly prolongMETexon14Skip mutation typeNSCLCThe survival period of patients, providing patients with longer survival period and better quality of life.
4. Personalized treatment options: Because capmatinib is a representative of precision medicine, its therapeutic effect is mainly reflected in patients with specific genetic variants, thus providing more individualized and targeted treatment options for patients with non-small cell lung cancer.
Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)